Our team
A multi disciplinary team of talented people, with over 120 years of cumulative experience

Our executive team

Edouard FONCK
CEO
Edouard has created and developed several innovative projects and start-ups in the healthcare field.
He has held key positions in several departments of successful startups and created his own incubator focusing on turning ideas and R&D into businesses.
Edouard holds a PhD in biomedical engineering from the Ecole Polytechnique Fédérale de Lausanne in Switzerland (EPFL) and a degree in chemical engineering from the University of California Santa Barbara in the United States.

An NGUYEN-DINH
FOUNDER
An has a long track record of successful achievements in R&D for diagnostic imaging and therapy. He has spent more than 30 years in MD Innovation with dozens of patents and publications.

Dalit SHAV
CLINICAL DIRECTOR
Dalit has extensive clinical development and clinical operations experience, including working with regulatory authorities and the medical and scientific community.
She has experience of clinical development at Philips, and has also worked at SoniVie Inc., a cardiovascular class III medical device, where she led both clinical and pre-clinical operations.
Dalit has a PhD and MSc in biomedical engineering from Tel-Aviv University and a BA in life sciences from the Hebrew University in Jerusalem.

Nicolas GRIFFATON
DEVELOPMENT DIRECTOR
Nicolas has long experience of leading multi-disciplinary R&D and innovation teams, in many fields before joining implantable cardiology medical devices in 2018.
He was strongly involved in hardware development of Carmat artificial heart, where he led development, verification and upstream team projects.
Nicolas has a MSc in Mechanical and Microtechnics Engineering from ENSMM in Besançon, France.

Alaa MAKDISSI
CTO
Alaa has more than 20 years’ experience leading R&D and an extensive background in medical device product and embedded development.
As a high-performing and hands-on technical leader with extensive experience in innovating and delivering complex projects, Alaa is a passionate innovator, and the author of scientific papers and patents related to cardiovascular medical devices.
He holds a degree in Engineering from the Centrale-Supélec and a PhD in signal processing and system control from the Orsay-Paris XIII university in France.

Wolfgang WERNER
QA/RA DIRECTOR
Wolfgang is a 30-year experience professional with successful track record of bringing state-of the-art class 2 to active implantable medical products to market for several start-up companies.
He has established expertise in validation of reliable electronic and disposable medical devices. Set-up of domestic and international OEM-manufacturers to comply with internal quality system and regulatory requirements for commercial products.
He has a regulatory affairs experience with a strong engineering and active Implantable Medical Devices, mHealth and eHealth background.

Daniel KROISS
CHIEF SCIENTIFIC OFFICER
Daniel brings decades of expertise in cardiac rhythm management to Cairdac. Previously, he served as VP of R&D at Microport CRM, holding leadership roles in research, innovation, and business development since 1982.
He played a key role in groundbreaking advancements, including the first dual-chamber defibrillator (1995) and the world’s smallest defibrillator (2005), and is a recognized expert in implantable medical devices.
Daniel has led multi-functional teams in electronics, tele-cardiology, and integrated circuit development. He has also contributed to international medical device standards throughout his career.